Product Details

Mircera 75 mcg**

Methoxy polyethylene glycol-epoetin beta
75 mcg/0.3 mL
Solution for injection

ROA

Intravenous; Subcutaneous

Applicant Name

Roche Products Limited

NRN

A6-0106

Status

Active


Composition

Mircera 75 micrograms/0.3 mL solution for injection in pre-filled syringe. One pre-filled syringe contains 75 micrograms of Methoxy polyethylene glycol-epoetin beta* at a concentration of 250 micrograms/mL. The strength indicates the quantity of the protein moiety of the methoxy polyethylene glycol-epoetin beta molecule without consideration of the glycosylation. *Protein produced by recombinant DNA technology in Chinese Hamster Ovary (CHO) cells and covalently conjugated to a linear methoxy-polyethylene glycol (PEG). The potency of methoxy polyethene glycol-epoetin beta should not be compared to the potency of another pegylated or non-pegylated protein of the same therapeutic class Excipients: L-Methionine, Sodium sulphate anhydrous, Sodium dihydrogen phosphate monohydrate, Mannitol, Poloxamer 188, Hydrochloric acid, Sodium hydroxide (pH adjustment), Water for Injection (pH adjustment)  

ATC Code

B03XA03  

Product Category

Vaccines and Biologics

Marketing Category

Prescription-only Medicine (POM)  

Packsize

0.3 mL (75 µg) x 1’s (in prefilled syringe)  

Product Description

Solution for injection in pre-filled syringe. The solution is clear and colourless to slightly yellowish

Manufacturer Name

Roche Diagnostics GmbH

Manufacturer Country

GERMANY  

Approval Date

2023-07-03  

Expiry Date

2028-07-02